CompletedNot Applicable

Benchmarking an Oral Anticoagulant Treatment Rate in Patients With Nonvalvular Atrial Fibrillation

United States817 participantsStarted 2017-01

Plain-language summary

The purpose of this study is to establish a benchmark for rate of prescription of oral anticoagulants (OA) in patients with non-valvular atrial fibrillation (NVAF) seen in an ambulatory care setting, based on independent medical assessment of clinical data and physician and patient surveys. The study will also assess reasons for not prescribing OA to prevent thromboembolic complications in patients with NVAF seen in ambulatory care, and patients' perspectives of non-use of OA for treatment of NVAF.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: A patient must meet all of the following criteria to participate in this study: * Able and willing to complete the survey; * Diagnosed with nonvalvular atrial fibrillation and CHA2DS2-VASc ≥ 2; * Not currently treated with oral anticoagulants according to the PINNACLE Registry data; * Enrolled in the PINNACLE Registry; * Last physician office visit within the prior 18 months; and * Age ≥ 18 years. Exclusion Criteria: A patient will be excluded from participating in the study for any of the following reasons: * Patient is no longer being followed at the local practice; * Patient declines participation; and/or * Patient is unable to speak or read English.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

A benchmark rate of OA treatment in patients with NVAF

Timeframe: Baseline

Trial details

NCT IDNCT02919982

SponsorBaim Institute for Clinical Research

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2018-05

View on ClinicalTrials.gov More Nonvalvular Atrial Fibrillation trials